ESCMID*  	ESCMID*  	 NNP	B-NP
guideline  	guideline  	 NN	I-NP
for  	for  	 IN	O
the  	the  	 DT	O
diagnosis  	diagnosis  	 NN	O
and  	and  	 CC	O
management  	management  	 NN	O
of  	of  	 IN	O
Candida  	Candida  	 NNP	B-NP
diseases  	diseases  	 VBD	I-NP
2012 	2012 	 CD	O
:  	:  	 :	O
diagnostic  	diagnostic  	 JJ	B-NP
procedures  	procedures  	 NNS	I-NP
As  	As  	 IN	O
the  	the  	 DT	O
mortality  	mortality  	 NN	O
associated  	associated  	 VBN	O
with  	with  	 IN	O
invasive  	invasive  	 JJ	B-NP
Candida  	Candida  	 JJ	I-NP
infections  	infections  	 NN	I-NP
remains  	remains  	 VBZ	O
high 	high 	 JJ	O
,  	,  	 ,	O
it  	it  	 PRP	O
is  	is  	 VBZ	O
important  	important  	 JJ	O
to  	to  	 TO	O
make  	make  	 VB	O
optimal  	optimal  	 JJ	B-NP
use  	use  	 NN	I-NP
of  	of  	 IN	O
available  	available  	 JJ	O
diagnostic  	diagnostic  	 JJ	B-NP
tools  	tools  	 NNS	I-NP
to  	to  	 TO	O
initiate  	initiate  	 VB	O
antifungal  	antifungal  	 JJ	B-NP
therapy  	therapy  	 NN	I-NP
as  	as  	 IN	O
early  	early  	 JJ	O
as  	as  	 IN	O
possible  	possible  	 JJ	O
and  	and  	 CC	O
to  	to  	 TO	O
select  	select  	 VB	O
the  	the  	 DT	O
most  	most  	 RBS	O
appropriate  	appropriate  	 JJ	O
antifungal  	antifungal  	 JJ	B-NP
drug 	drug 	 NN	I-NP
.  	.  	 .	O
A  	A  	 DT	O
panel  	panel  	 NN	O
of  	of  	 IN	O
experts  	experts  	 NNS	O
of  	of  	 IN	O
the  	the  	 DT	O
European  	European  	 NNP	O
Fungal  	Fungal  	 NNP	O
Infection  	Infection  	 NNP	O
Study  	Study  	 NNP	O
Group  	Group  	 NNP	O
( 	( 	 -LRB-	O
EFISG 	EFISG 	 NNP	B-NP
)  	)  	 -RRB-	O
of  	of  	 IN	O
the  	the  	 DT	O
European  	European  	 NNP	O
Society  	Society  	 NNP	O
of  	of  	 IN	O
Clinical  	Clinical  	 NNP	B-NP
Microbiology  	Microbiology  	 NNP	I-NP
and  	and  	 CC	O
Infectious  	Infectious  	 NNP	B-NP
Diseases  	Diseases  	 NNP	I-NP
( 	( 	 -LRB-	O
ESCMID 	ESCMID 	 NNP	B-NP
)  	)  	 -RRB-	O
undertook  	undertook  	 VBD	O
a  	a  	 DT	O
data  	data  	 NN	O
review  	review  	 NN	O
and  	and  	 CC	O
compiled  	compiled  	 VBN	B-NP
guidelines  	guidelines  	 NNS	I-NP
for  	for  	 IN	I-NP
the  	the  	 DT	I-NP
clinical  	clinical  	 JJ	I-NP
utility  	utility  	 NN	I-NP
and  	and  	 CC	O
accuracy  	accuracy  	 NN	B-NP
of  	of  	 IN	O
different  	different  	 JJ	O
diagnostic  	diagnostic  	 JJ	B-NP
tests  	tests  	 NNS	I-NP
and  	and  	 CC	O
procedures  	procedures  	 NNS	O
for  	for  	 IN	O
detection  	detection  	 NN	O
of  	of  	 IN	O
Candida  	Candida  	 NNP	B-NP
infections 	infections 	 NNS	I-NP
.  	.  	 .	O
Recommendations  	Recommendations  	 NNS	B-NP
about  	about  	 IN	O
the  	the  	 DT	O
microbiological  	microbiological  	 JJ	B-NP
investigation  	investigation  	 NN	I-NP
and  	and  	 CC	O
detection  	detection  	 NN	O
of  	of  	 IN	O
candidaemia 	candidaemia 	 NN	B-NP
,  	,  	 ,	O
invasive  	invasive  	 JJ	B-NP
candidiasis 	candidiasis 	 NN	I-NP
,  	,  	 ,	O
chronic  	chronic  	 JJ	B-NP
disseminated  	disseminated  	 JJ	I-NP
candidiasis 	candidiasis 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
oropharyngeal 	oropharyngeal 	 NN	B-NP
,  	,  	 ,	O
oesophageal 	oesophageal 	 NN	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
vaginal  	vaginal  	 JJ	B-NP
candidiasis  	candidiasis  	 NN	I-NP
were  	were  	 VBD	O
included 	included 	 VBN	O
.  	.  	 .	O
In  	In  	 IN	O
addition 	addition 	 NN	B-NP
,  	,  	 ,	O
remarks  	remarks  	 NNS	O
about  	about  	 IN	O
antifungal  	antifungal  	 JJ	B-NP
susceptibility  	susceptibility  	 JJ	I-NP
testing  	testing  	 NN	I-NP
and  	and  	 CC	O
therapeutic  	therapeutic  	 JJ	B-NP
drug  	drug  	 NN	I-NP
monitoring  	monitoring  	 NN	I-NP
were  	were  	 VBD	O
made 	made 	 VBN	O
.  	.  	 .	O
